|
DCAF12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.941580E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.235900E-02 |
| Normal-vs-Stage2 |
5.195000E-01 |
| Normal-vs-Stage3 |
9.657600E-01 |
| Normal-vs-Stage4 |
9.333000E-01 |
| Stage1-vs-Stage2 |
5.163400E-01 |
| Stage1-vs-Stage3 |
1.591590E-01 |
| Stage1-vs-Stage4 |
3.258000E-01 |
| Stage2-vs-Stage3 |
6.069200E-01 |
| Stage2-vs-Stage4 |
6.623400E-01 |
| Stage3-vs-Stage4 |
9.477800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.417830E-01 |
| Normal-vs-AfricanAmerican |
3.412800E-01 |
| Normal-vs-Asian |
1.676770E-01 |
| Caucasian-vs-AfricanAmerican |
7.979800E-01 |
| Caucasian-vs-Asian |
7.204800E-01 |
| AfricanAmerican-vs-Asian |
5.921800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.249500E-02 |
| Normal-vs-Female |
7.118200E-01 |
| Male-vs-Female |
4.254100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.009640E-01 |
| Normal-vs-Extreme_Weight |
5.478200E-03 |
| Normal-vs-Obese |
8.155400E-01 |
| Normal-vs-Extreme_Obese |
4.292200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.597600E-01 |
| Normal_Weight-vs-Obese |
2.219600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.903000E-01 |
| Extreme_Weight-vs-Obese |
3.927700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.150600E-01 |
| Obese-vs-Extreme_Obese |
5.645600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.226400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.726400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.643700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.352420E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.939200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.234780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.794100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.576300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.040590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.106200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.488030E-01 |
| Normal-VS-Type2 PRCC |
2.282200E-02 |
| Normal-VS-KIRP CIMP |
1.802460E-02 |
| Normal-VS-Unclassified PRCC |
9.222200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.519800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.569900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.035600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.83900000000548E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.266180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.584600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.218250E-02 |
| Normal-vs-N1 |
4.273600E-01 |
| Normal-vs-N2 |
1.681790E-01 |
| N0-vs-N1 |
8.188300E-02 |
| N0-vs-N2 |
8.920800E-01 |
| N1-vs-N2 |
4.248200E-01 |
|
|
